Nestle India Reports Rise in Quarterly Profit, Announces JV With Dr. Reddy's Laboratories
By Kosaku Narioka
Nestle India reported a rise in quarterly net profit on higher revenue and announced a new joint venture with Dr. Reddy's Laboratories.
The Indian unit of food and beverage company Nestle said Thursday that net profit rose 27% from a year earlier to 9.34 billion rupees ($112.1 million) for the three months ended March 31.
Revenue increased 9.0% from a year earlier to INR52.68 billion, thanks to broad-based sales growth.
Nestle India also said it agreed to set up a joint venture with Dr. Reddy's Laboratories to sell nutritional products by leveraging the pharmaceutical company's robust retail and distribution network.
Nestle India will have a call option to increase its stake in the JV to up to 60% after six years from 49% initially, it said.
Write to Kosaku Narioka at kosaku.narioka@wsj.com
(END) Dow Jones Newswires
April 25, 2024 06:32 ET (10:32 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Markets Brief: Economic Data Back on the Agenda With CPI in View
-
Six Sports Betting and iGaming Stocks Trading at a Discount
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations